Skip to main content

Johnson & Johnson vs Pfizer: Founders, CEOs and History

Johnson & Johnson was founded in 1886 by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson and is led by Joaquin Duato. Pfizer was founded in 1849 by Charles Pfizer, Charles Erhart and is led by Albert Bourla.

Company facts

Johnson & Johnson

Founded
1886
Headquarters
New Brunswick, New Jersey
Current CEO
Joaquin Duato
Employees
140,800

Pfizer

Founded
1849
Headquarters
New York, New York
Current CEO
Albert Bourla
Employees
75,000

Founders

Johnson & Johnson

  • Robert Wood Johnson

    Robert Wood Johnson (1845-1910) co-founded Johnson & Johnson in 1886 and served as its first president.

  • James Wood Johnson

    James Wood Johnson (1856-1932) co-founded J&J with his brothers in 1886. An engineer by trade, he designed the early manufacturing machinery that allowed the company to mass-produce sterile surgical dressings.

  • Edward Mead Johnson

    Edward Mead Johnson (1852-1934) co-founded J&J in 1886, bringing crucial sales and marketing expertise to the early business.

Johnson & Johnson founders in full

Pfizer

  • Charles Pfizer

    Pfizer possesses a historic, immigrant founding story, rooted entirely in the rapid industrial expansion of 19th-century Brooklyn and defined by an effective, intensely meticulous German chemist and his ambitious confectioner cousin.

  • Charles Erhart

    Charles Erhart's role in Pfizer's founding is less celebrated than his cousin's, partly because the company carries Charles Pfizer's name and partly because his commercial contributions were less visible than the scientific achievements that drove the company'…

Pfizer founders in full

CEOs and their tenures

Johnson & Johnson

  1. Ralph Larsen1989–2002

    Former Chairman and Chief Executive Officer

    Larsen's acquisitions, including Neutrogena, Cordis, DePuy, and Centocor, broadened J&J into medical devices and biologics, laying groundwork for today's MedTech segment and immunology franchise.

    Source
  2. William Weldon2002–2012

    Former Chairman and Chief Executive Officer

    Weldon's later years were overshadowed by a wave of consumer product recalls, including Tylenol and Motrin, tied to manufacturing-quality problems.

    Source
  3. Alex Gorsky2012–2022

    Former Chairman and Chief Executive Officer

    Gorsky's tenure set up the 2023 Kenvue separation completed under his successor and saw J&J's single-dose COVID-19 vaccine authorized in 2021. He also oversaw the $30 billion Actelion acquisition in 2017 and the early years of talc litigation.

    Source
  4. Joaquin Duato2022–present

    Chairman and Chief Executive Officer

    Under Duato, J&J's sales reached $94.193 billion in FY2025 with $26.804 billion in net earnings, and the company guides to its first $100 billion year in 2026. He also launched the DePuy Synthes separation and the 2026 talc settlement proposal.

    Source
Johnson & Johnson CEO history in full

Pfizer

  1. Ian Read2010–2018

    Chief Executive Officer

    He ruthlessly cut R&D spending and eliminated tens of thousands of jobs, significantly boosting short-term earnings per share despite massive patent cliffs for blockbuster drugs like Lipitor.

    Source
  2. Albert Bourla2019–present

    Chairman and Chief Executive Officer

    A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.

    Source
  3. Dave Denton2022–2026

    Chief Financial Officer

    As CFO, he aggressively restructured the balance sheet following the Seagen acquisition, prioritizing debt reduction while defending the dividend.

    Source
  4. Chris Boshoff2025–present

    Chief Scientific Officer and President, Research & Development

    He completely restructured the research and development organization to focus on antibody-drug conjugates (ADCs), aggressively expanding Pfizer's pipeline of cancer therapeutics.

    Source
  5. Cecile Guegan2026–present

    Interim Chief Financial Officer

    She modernized the company's internal auditing and compliance structures, ensuring rapid but safe clinical execution for high-priority vaccine programs.

    Source
Pfizer CEO history in full

Timeline: Johnson & Johnson and Pfizer side by side

  1. 1849Pfizer

    Pfizer Founded

    Charles Pfizer and Charles Erhart founded the company in Brooklyn.

  2. 1886Johnson & Johnson

    Johnson & Johnson Founded

    Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson found the company in New Brunswick, New Jersey, with 14 employees, to mass-produce sterile surgical dressings after Robert was inspired by antiseptic pioneer Joseph Lister's 1885 warnings about i…

  3. 1920Johnson & Johnson

    Band-Aid Brand Adhesive Bandages Introduced

    J&J introduces the first mass-produced adhesive bandage, sold under the Band-Aid brand starting in 1921; it becomes one of the most recognized consumer-health brands in the world before J&J later spins its consumer division out as Kenvue in 2023.

  4. 1943Johnson & Johnson

    Robert Wood Johnson II Writes 'Our Credo'

    Chairman Robert Wood Johnson II authors 'Our Credo,' a one-page statement ranking the company's responsibilities to customers, employees, communities, and shareholders in that order; it remains J&J's official governing philosophy and was later cited as the bas…

  5. 1944Johnson & Johnson

    J&J Goes Public

    Johnson & Johnson lists publicly, becoming an independent, market-traded company as it expands into a diversified healthcare business under Chairman Robert Wood Johnson II.

  6. 1944Pfizer

    Penicillin Scale-Up

    Pfizer helped industrialize penicillin production during World War II.

  7. 1982Johnson & Johnson

    Tylenol Cyanide Poisonings and Nationwide Recall

    After seven people in the Chicago area die from cyanide-laced Extra-Strength Tylenol capsules, J&J issues a nationwide recall of 31 million bottles within a week -- far beyond what investigators said was necessary -- citing Our Credo's customer-safety priority…

  8. 1998Pfizer

    Viagra Approved

    The FDA approved Viagra in 1998.

  9. 2000Pfizer

    Warner-Lambert Deal

    Pfizer acquired Warner-Lambert, adding Lipitor.

  10. 2009Pfizer

    Wyeth Acquired

    Pfizer bought Wyeth in 2009 for about $68 billion.

  11. 2012Johnson & Johnson

    Alex Gorsky Becomes CEO

    Gorsky succeeds William Weldon as CEO amid a period of manufacturing-quality recalls, and spends the next decade restoring J&J's operational reputation while expanding the pharmaceutical and MedTech businesses and developing a single-dose COVID-19 vaccine duri…

  12. 2017Johnson & Johnson

    Actelion Acquired

    Johnson & Johnson bought the Swiss drugmaker Actelion in 2017 for about $30 billion.

  13. 2019Pfizer

    Albert Bourla becomes CEO

    Albert Bourla became CEO of Pfizer in 2019. A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.

  14. 2020Pfizer

    BioNTech COVID Vaccine Partnership

    Pfizer and BioNTech brought Comirnaty through emergency authorization.

  15. 2022Johnson & Johnson

    Joaquin Duato Becomes CEO

    Duato becomes CEO in January 2022, later adding the chairman title, and begins preparing the separation of J&J's consumer-health business from its medicine and device operations.

  16. 2023Johnson & Johnson

    Kenvue Separation

    J&J completes the spinoff of its consumer-health business (Band-Aid, Tylenol, Listerine, Neutrogena) as the standalone public company Kenvue, narrowing J&J around its higher-margin Innovative Medicine and MedTech segments.

  17. 2023Pfizer

    Seagen Acquisition

    Pfizer completed the $43 billion Seagen acquisition.

  18. 2025Johnson & Johnson

    FY2025 Sales of $94.193B

    Johnson & Johnson reports $94.193 billion in sales and $26.804 billion in net earnings, split roughly 64% Innovative Medicine and 36% MedTech, both segments growing about 6% year over year.

  19. 2025Johnson & Johnson

    Orthopaedics Separation Announced

    In October 2025 J&J announced plans to separate its orthopaedics business as a standalone company operating as DePuy Synthes, targeting completion in 2027.

  20. 2025Pfizer

    Chris Boshoff Becomes CSO

    Chris Boshoff became Chief Scientific Officer and President, Research & Development effective January 1, 2025.

  21. 2025Pfizer

    Metsera Acquisition

    Pfizer completed its acquisition of obesity drug developer Metsera in November 2025 for up to about $10 billion including CVRs.

  22. 2025Pfizer

    FY2025 Revenue Base

    Pfizer reported $62.579 billion of FY2025 revenue.

  23. 2026Johnson & Johnson

    Proposed Talc Resolution and Raised Guidance

    J&J raised 2026 sales guidance to about $101.1 billion after Q2 sales of $25.31 billion, and on July 27, 2026 proposed an estimated $5.5 billion resolution of remaining ovarian talc claims.

  24. 2026Pfizer

    Innovent Oncology Collaboration

    Pfizer signed a 12-program cancer collaboration with Innovent Biologics: $650 million upfront and up to $9.85 billion in milestones.

Acquisitions

Johnson & Johnson

  • Intra-Cellular Therapies2025$14.6B
  • Shockwave Medical2024$13.1B
  • Kenvue separation2023Undisclosed
  • Abiomed2022$16.6B
  • Actelion2017$30B
All Johnson & Johnson acquisitions

Pfizer

  • Metsera, Inc.2025$7B
  • Seagen Inc.2023$43B
  • Medivation Inc.2016$14B
  • Wyeth2009$68B
  • Pharmacia Corporation2003$60B
  • Warner-Lambert Company2000$111B
All Pfizer acquisitions

Questions about Johnson & Johnson vs Pfizer

Who is the CEO of Johnson & Johnson and Pfizer Inc.?

Johnson & Johnson is led by Joaquin Duato and Pfizer Inc. is led by Albert Bourla. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.

When was Johnson & Johnson founded vs Pfizer Inc.?

Pfizer Inc. was founded in 1849 — 37 years before Johnson & Johnson, which was founded in 1886. Pfizer Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Johnson & Johnson.

How many employees does Johnson & Johnson have compared to Pfizer Inc.?

Johnson & Johnson employs approximately 140,800 people, while Pfizer Inc. employs approximately 75,000. Johnson & Johnson has the larger workforce at 140,800 employees, compared to Pfizer Inc.'s 75,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).

Where are Johnson & Johnson and Pfizer Inc. headquartered?

Both Johnson & Johnson and Pfizer Inc. are headquartered in United States. Their local rules and tax obligations may still differ.

Who founded Johnson & Johnson and Pfizer Inc.?

Johnson & Johnson was founded by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson. Pfizer Inc. was founded by Charles Pfizer, Charles Erhart.

Which company has a longer operating history — Johnson & Johnson or Pfizer Inc.?

Pfizer Inc. has been operating for approximately 177 years, making it the more established of the two companies. Johnson & Johnson has been in operation for around 140 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Johnson & Johnson vs Pfizer overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.